comprehensive -WSS

comprehensive

author：comprehensive 2025-09-30 22:41:13 - browse：822

Bernard Moss, a research scientist at NIAID. -- Infectious disease coverage from STAT — Bernard Moss Courtesy NIAID

For more than half a century, scientist Bernard Moss has been commanding the attention of peers interested in prying biological secrets from poxviruses and other microbiological targets. Now he’s commanding the attention of a different audience: House Republicans.

Moss, who will mark his 86th birthday in late July and who goes by Bernie, has worked for more than 55 years in the laboratories of the National Institute of Allergy and Infectious Diseases in Bethesda, Md. Over that time, he has been investigating viruses in relative anonymity — except, that is, among the virological cognoscenti.

But last year, in an interview with Science, Moss said he planned to try to determine why one strain of mpox viruses, known as Clade 1, is so much more virulent than those in a second strain, Clade 2, by taking genes from the former and putting them into the latter. Clade 2 viruses are responsible for the ongoing mpox outbreak first detected in May 2022.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： It's time to retire 'poor historian' from clinicians' vocabularies

WSS

Inside the fall of star MIT scientist David Sabatini

Did the public have the right to know Arthur Ashe had AIDS?

Pfizer's Covid pill remains 89% effective in final analysis, company says

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

Glen Campbell's doctor discusses his public struggle with Alzheimer's

New case study details death in closely watched Alzhiemer's trial

explore

comprehensive

leisure time

Novavax promises a turnaround & Lilly roils the obesity market

Can food be medicine? And other questions about a new push

Activists slam private health insurers over coverage restrictions

Doctor appointment wait times are getting worse

Virginia high school admissions case could be legal follow

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

Medicare details structure of new drug price negotiation program

Arc Institute generative AI designs new CRISPR systems

Walensky prepares to leave CDC — and Congress — behind

Listen: PBM conflicts, RSV vaccines, & the future of flu season

Wikipedia

NVIDIA and Google execs on the future of AI and drug discovery

Option Care buys Amedisys in $3.6 billion home care deal

Solving academic medical centers' existential crisis

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

Second House panel advances two

explore

focus

hotspot

hotspot